ANDLAUER HEALTHCARE GROUP INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.54 CAD | -0.05% |
|
-0.84% | +1.37% |
| Sales 2024 * | 681M 498M | Sales 2025 * | 714M 522M | Capitalization | 1.72B 1.25B |
|---|---|---|---|---|---|
| Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 2.5 x |
| Net cash position 2024 * | 12.5M 9.14M | Net cash position 2025 * | 104M 76.39M | EV / Sales 2025 * | 2.26 x |
| P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 2,290 |
| Yield 2024 * |
1.01% | Yield 2025 * |
1.2% | Free-Float | 46.48% |
More Fundamentals
* Assessed data
More news
Latest transcript on Andlauer Healthcare Group Inc.
More recommendations
More press releases
| 1 day | -0.05% | ||
| 1 week | -0.84% | ||
| Current month | -2.19% | ||
| 1 month | -2.94% | ||
| 3 months | +4.58% | ||
| 6 months | +12.06% | ||
| Current year | +1.37% |
1 week
41.03
42.61
1 month
41.0343.41
Current year
38.1544.12
1 year
36.7651.72
3 years
34.5355.97
5 years
18.0055.97
10 years
18.0055.97
| Managers | Title | Age | Since |
|---|---|---|---|
Michael Andlauer
CEO | Chief Executive Officer | 59 | 19-11-11 |
Peter Bromley
DFI | Director of Finance/CFO | 60 | 18-12-31 |
Graham Cromb
PRN | Corporate Officer/Principal | - | 23-05-03 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Michael Andlauer
CEO | Chief Executive Officer | 59 | 19-11-11 |
| Director/Board Member | 51 | 19-11-11 | |
Thomas Wellner
BRD | Director/Board Member | 59 | 19-11-11 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.45% | 11 M€ | -.--% | ||
| 0.06% | 1 M€ | -.--% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 41.54 | -0.05% | 9,775 |
| 24-04-25 | 41.56 | -0.62% | 29,433 |
| 24-04-24 | 41.82 | -0.45% | 7,171 |
| 24-04-23 | 42.01 | +0.26% | 4,669 |
| 24-04-22 | 41.9 | +0.02% | 7,506 |
Delayed Quote Toronto S.E., April 26, 2024 at 04:00 pm
More quotes
Andlauer Healthcare Group Inc. is a Canada-based supply chain management company. It offers robust platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector. Its segments include Specialized Transportation and Healthcare Logistics. The Specialized Transportation segment offers temperature-controlled, as well as non-temperature controlled, ground transportation, air freight forwarding and last mile transportation services to its clients under its ATS Healthcare, ATS Dedicated, Boyle Transportation and Skelton Truck Lines brands. The Healthcare Logistics segment offers logistics and distribution services and packaging solutions to its clients under its Accuristix and LSU brands. It offers services to healthcare manufacturers, wholesalers, distributors and 3PL providers, through its technology-enabled supply chain solutions for a range of products, including pharmaceuticals, vaccines, biologics, blood products and others.
Calendar
2024-05-01
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
41.54
CAD
Average target price
50.93
CAD
Spread / Average Target
+22.60%
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +1.37% | 1.25B | |
| -14.92% | 84.68B | |
| +13.30% | 81.12B | |
| +10.92% | 29.4B | |
| -12.71% | 16.73B | |
| -3.06% | 16.36B | |
| -2.63% | 14.92B | |
| -31.75% | 11.77B | |
| -1.42% | 11.72B | |
| +27.44% | 11.71B |
- Stock Market
- Equities
- AND Stock
